International Precision Medicine Conference
April 19-21, 2021 | Virtual Event
Scopus Indexed Conference
Online Event
Phone : 1 (702) 988 2320
Toll Free: 1800–883-8082
Whatsapp: +1 (540) 709-1879
Email: precision@magnus-event.com
Toll Free: 1800–883-8082
Whatsapp: +1 (540) 709-1879
Email: precision@magnus-event.com
Title : Evaluation of clinical effectiveness of using enzyme-linked immunosorbent assay (ELISA) tests for measuring drug levels and/or their anti-drug antibodies for the purpose of monitoring treatment response and guiding decisions about the use of tumour necrosi
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Personalized and precision medicine as a unique healthcare model through the view of biodesign and translational armamentarium of the newest generation
Sergey Suchkov, Moscow Engineering Physical Institute, Russia
Title : Update on patent eligibility in the United states: Precision medicine in the cross-hairs
Jeffrey K. Mills, Medler Ferro Woodhouse & Mills, USA
Title : Keeping cancer in remission - A consensus from patients
Xu Chen, University of the Rockies, USA
Title : Targeting high-grade anaplastic astrocytoma and glioblastoma with a first-in class anti-tgf?2 RNA therapeutic administered by convection-enhanced delivery
Fatih Uckun, Oncotelic, USA
Title : The process of oncology nurse practitioner patient navigation: A grounded theory approach towards a navigation theory
Frances Mary Johnson , Privia Medical Group, USA
Title : Precision Medicine in Chronic Disease
Laura Kelly, CEO of Opal Health, California
Title : Pathogenicity of cancer alterations when the genotype and expected phenotype do not match: an integrated evaluation of germline and somatic genomic results
Arezou A. Ghazani, Harvard Medical School
Title : Pain: an opioid epidemic requiring a non-opioid alternative
Sean Hall, Medlab Clinical LTD, Australia
Title : The Role of Metabolomics in Precision Medicine of Osteoarthritis: Where Are We Now?
Guangju Zhai, Memorial University of Newfoundland, Canada
Title : Antibody-Proteases as a novel biomarker and a unique target to suit translational tools to be applied for Biodesign, Bioengineering and Regenerative medicine
Sergey Suchkov, Moscow Engineering Physical Institute, Russia
Title : MicroARNs are biomarkers of cardiovascular events due to Chronic Kidney Disease
Laurent Metzinger, Universite de Picardie Jules Verne, France
Title : Functionalized Red Carbon Nanodots for Precision Cancer Chemo-Phototherapy
Nicolo Mauro, University of Palermo, Italy
Title : Predictive, precise, personalized and prognostic medicine for NAFDL, NASH and Liver cancers in sub-saharan africa: Challenges, solutions and perspectives
Benjamin Longo Mbenza, University of Kinshasa, DR Congo